Article
News briefing: Catalent, Merck KGaA make big investments in manufacturing ops; J&J teams with Datav
Rating:
0.0
Views:
143
Likes:
1
Library:
1
We're continuing to see big investments in the global biopharma manufacturing infrastructure. Wednesday morning Catalent put out the word that it is investing $130 million in its late-stage ops at its gene therapy facility in Harmans, MD. The contract manufacturer has been sinking a significant amount of money into gene
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value